Antihyperlipidemics: Statins, Fibrates & Bile Acid Resins with Lipid Targets
#Antihyperlipidemics #Statins #Hyperlipidemia #Dyslipidemia #iPrkashMishra

Antioxidants may lower death risk with high cholesterol Curated by <b>Smartbrief</b>. A study published in <a href="https://www.nature.com/articles/s41598-025-23753-x" target="_blank" rel="noopener">Scientific Reports</a> analyzed data from over 25,000 adu...

Índice de antioxidantes de la dieta elevado, especialmente vit E, asoc c/reducción en mortalidad por todas las causas, por enfermedad CV y por cáncer en los pacientes hiperlipidémicos, parcialmente mediado por la inflamación #antioxidants #Hyperlipidemia newsletter.smartbrief.com/sharedSummar...

Synthesis and characterization of surfactants derived from phenolphthalein

This Open Chemistry study reports the synthesis of novel phenolphthalein-based #Surfactants with potential anti-hyperlipidemic effects, demonstrated both in vivo & in silico, highlighting their therapeutic benefits against #Hyperlipidemia.
#OpenAccess: doi.org/10.1515/chem...

#Hyperlipidemia activates C/EBPβ to drive #VSMCs toward a macrophage-like phenotype, promoting #ArterialStiffness, while C/EBPβ loss alleviates #VascularRemodeling and identifies PDGF-CC as a potential #biomarker of human arterial stiffness.

#STTT: doi.org/10.1038/s413...

Groundbreaking Gene Editing Therapy Targets APOC3 to Address Hyperlipidemia CorrectSequence Therapeutics has unveiled the first gene editing treatment targeting APOC3 to combat hyperlipidemia, marking a major milestone in medical biotechnology.

Groundbreaking Gene Editing Therapy Targets APOC3 to Address Hyperlipidemia #China #Shanghai #gene_therapy #CorrectSequence #Hyperlipidemia

First Gene-Editing Therapy Targeting APOC3 Marks a Milestone for Hyperlipidemia Treatment CorrectSequence Therapeutics has achieved a groundbreaking milestone by successfully administering the first-ever gene-editing therapy targeting APOC3 for hyperlipidemia patients. This innovation could mean a significant shift in treatment protocols.

First Gene-Editing Therapy Targeting APOC3 Marks a Milestone for Hyperlipidemia Treatment #China #Shanghai #CorrectSequence #Hyperlipidemia #APOC3

Revolutionizing Hyperlipidemia Treatment: Gene-Editing Therapy by CorrectSequence Therapeutics CorrectSequence Therapeutics introduces the world's first gene-editing therapy targeting APOC3, marking a significant breakthrough in hyperlipidemia treatment.

Revolutionizing Hyperlipidemia Treatment: Gene-Editing Therapy by CorrectSequence Therapeutics #China #Shanghai #CorrectSequence #gene-editing #Hyperlipidemia

Approval of Ongericimab Injection by China NMPA

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#NMPAApproval #OngericimabInjection #JunshiBiosciences #PCSK9Inhibitor #CholesterolTreatment #Hyperlipidemia #InnovativeMedicine #ChinaBiopharma

Research Highlights Risks Associated with High Cholesterol in Pregnant Women Recent findings reveal that pregnant women with high cholesterol may face serious cardiovascular risks and complications during and after pregnancy.

Research Highlights Risks Associated with High Cholesterol in Pregnant Women #United_States #Pittsburgh #Cardiovascular_Risk #Allegheny_General_Hospital #Hyperlipidemia

Nutraceuticals Against the Silent Killers: Role of Secondary Metabolites in the Prevention and Management of Hypertension and Hyperlipidemia - Premier Science Quercetin, Epigallocatechin-3-gallate, Anthocyanins, ace inhibition, cetp inhibitions, Nutraceuticals, management of hypertension and hyperlipidemia

premierscience.com/pjc-25-1263/

#nutraceuticals #metabolites #hypertension #hyperlipidemia

COX7C alleviates lipid accumulation and apoptosis in hyperlipidemia models via HIF-1α pathway Introduction: Background: One of the main contributing factors to the growth of atherosclerosis is hyperlipidemia (HLP). COX7C is a mitochondrial protein that is essential to mitochondrial function a...

Just Released ONLINE: #COX7C alleviates #lipid accumulation and #apoptosis in #hyperlipidemia models via HIF-1α #pathway.

www.archivesofmedicalscience.com/COX7C-allevi...

This study provides molecular insights into how C/EBPβ activation in #hyperlipidemia induces the phenotypic transition of contractile VSMCs to macrophage-like cells and promotes #ArterialStiffness. #medsky

#STTT #OpenAccess article here: doi.org/10.1038/s413...

Sequential bilateral retinal artery occlusions with promising visual prognosis in a diabetic patient: a case report and literature review Metabolic disorders, like hyperlipidemia and diabetes, are high-risk factors for developing retinal artery occlusion. Timely intra-arterial thrombolysis in this case was crucial for preserving the…

#MedCase - Metabolic disorders, like #hyperlipidemia and #diabetes, are high-risk factors for developing retinal artery occlusion.

Timely intra-arterial thrombolysis in this case was crucial for preserving the patient's vision.

👉 buff.ly/eiLZjjM

#EyeSky #RAO

Merck reports positive Phase III results for oral PCSK9 inhibitor Merck’s investigational oral drug enlicitide showed significant LDL-C reduction in two Phase III trials for hyperlipidemia.

Merck (MSD) has announced positive topline results from the first two Phase III trials of enlicitide decanoate, an investigational oral PCSK9 inhibitor for the treatment of adults with hyperlipidemia. Both trials met their primary and key secondary endpoints.

#news #clinicaltrial #hyperlipidemia

Merck reports positive Phase III results for oral PCSK9 inhibitor Merck’s investigational oral drug enlicitide showed significant LDL-C reduction in two Phase III trials for hyperlipidemia.

Merck (MSD) has announced positive topline results from the first two Phase III trials of enlicitide decanoate, an investigational oral PCSK9 inhibitor for the treatment of adults with hyperlipidemia. Both trials met their primary and key secondary endpoints.

#news #clinicaltrial #hyperlipidemia

Merck’s cholesterol drug meets main goal in two studies (Reuters) -Merck said on Monday its drug met the main goal of reducing a type of cholesterol in two late-stage studies. The drug, enlicitide decanoate, is being evaluated as a treatment for hyperlipidemia, a condition where there is elevated buildup of fat in the blood vessels. Enlicitide was tested in patients who have a history of, or are at risk for heart disease.

Click Subscribe #Cholesterol #HeartHealth #Hyperlipidemia #Merck #Pharmaceuticals

Canada will NOT, I repeat WILL NOT become the US’s 51st state!!

The US and Canada are neighbors, this is crazy!

#dumptrump
#fuckmusk
#hyperlipidemia
#heartdisease

#🤞🏼🤞🏽🤞🏻🤞🏾🤞🤞🏿

#hopehe’sgone
#please,please,please

youtube.com/shorts/Vhsyt...

LDL? HDL? VLDL? Get clarity on those confusing acronyms in your cholesterol report from Dr. Adi Chandrasekhar, Primary.Health Medical Director.

https://buff.ly/416VCVz

#cholesterol #hyperlipidemia #wellness #prevention

Zodasiran, an RNAi therapy, targets ANGPTL3, showing significant reductions in triglycerides and LDL in patients with mixed hyperlipidemia. A leap toward lower cardiovascular risk! #ANGPTL3 #RNAi #Hyperlipidemia PMID:38809174, N Engl J Med 2024

Page Not Found!

Related. Another reason Hub may die young (and I might go to hell). http://tiny.cc/9rsvx #hyperlipidemia #baconjamming